日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study

与预后良好型肾母细胞瘤复发相关的基因改变:儿童肿瘤协作组AREN03B2研究

Samantha Gadd ,Vicki Huff ,Andrew D Skol ,Lindsay A Renfro ,Conrad V Fernandez ,Elizabeth A Mullen ,Corbin D Jones ,Katherine A Hoadley ,Kai Lee Yap ,Nilsa C Ramirez ,Sheena Aris ,Quy H Phung ,Elizabeth J Perlman

Wilm's tumor 1 promotes memory flexibility

Wilm's 肿瘤 1 促进记忆灵活性

Chiara Mariottini,Leonardo Munari,Ellen Gunzel ,Joseph M Seco,Nikos Tzavaras,Jens Hansen ,Sarah A Stern ,Virginia Gao ,Hossein Aleyasin,Ali Sharma,Evren U Azeloglu,Georgia E Hodes,Scott J Russo,Vicki Huff,Marc R Birtwistle ,Robert D Blitzer,Cristina M Alberini ,Ravi Iyengar

Knock-in of the Wt1 R394W mutation causes MDS and cooperates with Flt3/ITD to drive aggressive myeloid neoplasms in mice

Wt1 R394W 突变敲入可导致 MDS,并与 Flt3/ITD 协同作用,引发小鼠侵袭性髓系肿瘤

Colleen E Annesley, Cara Rabik, Amy S Duffield, Rachel E Rau, Daniel Magoon, Li Li, Vicki Huff, Donald Small, David M Loeb, Patrick Brown

Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation

在 β-Catenin 激活或 Wt1 消融和 Igf2 上调的小鼠模型中,肾元祖细胞而非基质祖细胞会形成 Wilms 肿瘤

Le Huang, Sharada Mokkapati, Qianghua Hu, E Cristy Ruteshouser, M John Hicks, Vicki Huff

MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours

MLLT1 YEATS 结构域突变在临床上具有独特优势的组织学 Wilms 肿瘤中

Elizabeth J Perlman, Samantha Gadd, Stefan T Arold, Anand Radhakrishnan, Daniela S Gerhard, Lawrence Jennings, Vicki Huff, Jaime M Guidry Auvil, Tanja M Davidsen, Jeffrey S Dome, Daoud Meerzaman, Chih Hao Hsu, Cu Nguyen, James Anderson, Yussanne Ma, Andrew J Mungall, Richard A Moore, Marco A Marra, 

Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: early metabolic response without inhibition of tumor growth

使用 18F-FDG PET 和双重对比增强 CT 和 MRI 监测 MEK 抑制剂 U0126 在 Wt1 敲除 Igf2 转基因小鼠的新型 Wilms 肿瘤模型中的治疗效果:早期代谢反应未抑制肿瘤生长

Leo G Flores 2nd, Hsin-Hsien Yeh, Suren Soghomonyan, Daniel Young, James Bankson, Qianghua Hu, Mian Alauddin, Vicki Huff, Juri G Gelovani

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

小鼠中 Wt1 消融和 Igf2 上调导致 Wilms 肿瘤 ERK1/2 磷酸化升高

Qianghua Hu, Fei Gao, Weihua Tian, E Cristy Ruteshouser, Yaqing Wang, Alexander Lazar, John Stewart, Louise C Strong, Richard R Behringer, Vicki Huff

Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models

威尔姆斯肿瘤 1 (WT1) 调节小鼠和人类模型中 KRAS 驱动的肿瘤发生和衰老

Silvestre Vicent, Ron Chen, Leanne C Sayles, Chenwei Lin, Randal G Walker, Anna K Gillespie, Aravind Subramanian, Gregory Hinkle, Xiaoping Yang, Sakina Saif, David E Root, Vicki Huff, William C Hahn, E Alejandro Sweet-Cordero